Skip to content
Research Article Open access CC BY 4.0

Seroprevalence of Hepatitis B Virus among Blood Donors at National Blood Transfusion and Research Center-Taiz Branch, Yemen

Jamal M. S. Al-Khulidi, Mohammed Al-Taj, Ashwaq Ahmed Abdullah

Asian Journal of Research in Infectious Diseases · pp. 1–6 · Published 22 Jul 2024

10.9734/ajrid/2024/v15i8362

Abstract

Hepatitis B Virus (HBV) represents one of the most health problems. Almost more than 350 million infected persons were reported universally. Blood transfusion is commonly the most common route of transmission of HBV. Recently, Hospitals in Yemen are increasing demands for blood and blood products due to war injury, anemia, and malnutrition.  The risk of transfusion transmission of infection relatively increases. This study aimed to determine hepatitis B virus prevalence among blood donors at the National Blood Transfusion Center -Taiz branch (NBTRC- TB). Data was collected from the National Blood Transfusion and Research Center (Taiz branch) from 1/4/2020 to 16/12/2020. A total of 3174 blood donors donated blood at the center. A descriptive cross-sectional study was conducted on them. Blood donor information was registered at the reception department, and all blood screening tests were performed. Data of HBsAg and total anti-HBc were analyzed statistically by using IBM SPSS version 26. Among 3174 blood donors, male blood donors were 3158 (99.5%) and female blood donors 16 (0.5%). Furthermore, 41 (1.3%) were positive for HBsAg (which all the positive results were for male donors and no positivity were for female donors) while 353 (11.1%) were positive for total anti- HBc Ab which is distributed at ratio of 11% (350) for males and 0.1% (3) for females. On the other hand, the result of HBsAg and total anti-HBc Ab together showed three levels of positivity as the (HBsAg positive / anti-HBc negative) were 12 (0.4%) in which was a low percentage and reversely, the (HBsAg negative/ HBcAb positive) were 316 (10.2%), While the HBsAg positive / anti-HBc positive were 27 (0.9%). So this study shed light on the result of HBsAg negative/ anti-HBc positive which the percentage (10.2%) of which statistically significant (p. value = 0.000) and was the highest result indicates donors with post HBV infection or have low HBV infection.  This study showed the high prevalence of post-HBV infection among blood donors. Using both markers HBsAg and total anti-HBc Ab will improve the detection of HBV before blood transfusion.

HBV seroprevalence blood donors Taiz Yemen

References (34)

  1. 1 Chisari FV, Ferrari C, Mondelli MU. Hepatitis B virus structure and biology. Microb Pathog. 1989;6(5):311-25. [DOI]
  2. 2 Available: https://doi.org/10.1016/0882-4010(89)90073-9. [DOI]
  3. 3 Fopa D, Candotti D, Tagny CT, Doux C, Mbanya D, Murphy EL, et al. Occult hepatitis B infection among blood donors from Yaoundé, Cameroon. Blood Transfus. 2019;17(6):403.
  4. 4 Sallam TA, Raja'a YA, Bahaj S, Al-Shami AM, Lu M, Roggendorf M, Tong CY. Hepatitis B virus carrier rate, prevalence and susceptibility and impact of immunization program among households in the city of Taiz, Yemen. Vaccine. 2012;30(37):5564-8. [DOI]
  5. 5 Available:https://doi.org/10.1016/j.vaccine.2012.06.008. [DOI]
  6. 6 Thabit A, Al-Moyed K, Al-Balushi M, Hasson S, Sallam T. Occult hepatitis B virus among chronic liver disease patients in Yemen. Asian Pac J Trop Dis. 2012;2(1):4-6. [DOI]
  7. 7 Jayalakshmi M, Kalyanaraman N, Pitchappan R. Hepatitis B virus genetic diversity: Disease pathogenesis. Viral Replication. 2013;69. [DOI]
  8. 8 Ott J, Stevens G, Groeger J, Wiersma S. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212-9. [DOI]
  9. 9 Said B, Hassan R. Risk factors for hepatitis B virus among blood donors in Baghdad, Iraq. Int J Adv Res Med. 2019;1:62-7. Available:https://doi.org/10.22271/27069567.2019.v1.i2b.17. [DOI]
  10. 10 Alzahrani FM, Shaikh SS, Alomar AI, Acharya S, Elhadi N. Prevalence of Hepatitis B Virus (HBV) Among Blood Donors in Eastern Saudi Arabia: Results From a Five-Year Retrospective Study of HBV Seromarkers. Ann Lab Med. 2019;39(1):81-5. [DOI]
  11. 11 Moonsamy S, Suchard M, Pillay P, Prabdial-Sing N. Prevalence and incidence rates of laboratory-confirmed hepatitis B infection in South Africa, 2015 to 2019. BMC Public Health. 2022;22(1):1-13. [DOI]
  12. 12 Kabamba A, Kalunga B, Mwamba C, Nyembo C, Dufrasne F, Dessilly G, et al. Epidemiological aspects and molecular characterization of the hepatitis B virus among blood donors in Lubumbashi, Democratic Republic of Congo. Transfus Clin Biol. 2021;28(1):30-7. [DOI]
  13. 13 Akinbami AA, Oshinaike OO, Dosunmu OA, Adeyemo TA, Adediran A, Akanmu S, et al. Seroprevalence of hepatitis B e antigen (HBe antigen) and B core antibodies (IgG anti-HBcore and IgM anti-HBcore) among hepatitis B surface antigen positive blood donors at a Tertiary Centre in Nigeria. BMC Res Notes. 2012;5(1):1-5. [DOI]
  14. 14 Olotu AA, Oyelese AO, Salawu L, Audu RA, Okwuraiwe AP, Aboderin AO. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation. Virol J. 2016;13(1): 1-8. [DOI]
  15. 15 Alzubiery T, Alharazi T, Sumairi H, Al-Zubiery A. Sero-Prevalence of HBs Ag, HCV and HIV among Blood Donors in Three Blood Bank Centers in Sana'a city: Yemen. J Biotechnol Biomed Sci. 2017;1:26-32. [DOI]
  16. 16 Available:https://doi.org/10.1302/issn.2576-6694.jbbs-17-1853.
  17. 17 Alabdallat NG, Bin Dukhyil AAA. Significance of HBV NAT Among HBs Antigen-Negative Blood Donors in Saudi Arabia. Lab Med. 2018;49(4):342-6. Available:https://doi.org/10.1093/labmed/lmy023. [DOI]
  18. 18 Alzubiery T, Alharazi T, Sumairi H, Jabir A, Muckbil M, Saleh M. Prevalence of HbsAg and Anti-Hbc among Blood Donors at the National Blood Transfusion and Research Center, Sana'a, Yemen. World J Pharm Med Res. 2017;3(5):69-74. [DOI]
  19. 19 Haidar NA. Prevalence of hepatitis B and hepatitis C in blood donors and high risk groups in Hajjah, Yemen Republic. Saudi Med J. 2002;23(9):1090-4.
  20. 20 Sallam TA, Tong CY, Cuevas LE, Raja'a YA, Othman AM, Al-Kharsa KR. Prevalence of blood-borne viral hepatitis in different communities in Yemen. Epidemiol Infect. 2003;131(1):771-5. [DOI]
  21. 21 Available:https://doi.org/10.1017/s0950268803008653. [DOI]
  22. 22 Al-Waleedi AA, Khader YS. Prevalence of hepatitis B and C infections and associated factors among blood donors in Aden City, Yemen. East Mediterr Health J. 2012;18(6):624-9. [DOI]
  23. 23 Available:https://doi.org/10.26719/2012.18.6.624. [DOI]
  24. 24 Jadeja P, Kaur A, Shekha H. Trend in seroprevalence of hepatitis B virus Infection among blood donors at tertiary care centre of Rajasthan, India. J Med Res. 2014;4(3):205-7.
  25. 25 Khattab MA, Eslam M, Sharwae MA, Hamdy L. Seroprevalence of hepatitis C and B among blood donors in Egypt: Minya Governorate, 2000-2008. Am J Infect Control. 2010;38(8):640-1. [DOI]
  26. 26 Available:https://doi.org/10.1016/j.ajic.2009.12.016. [DOI]
  27. 27 Dray X, Dray-Spira R, Bronstein JA, Mattera D. Prevalences of HIV, hepatitis B and hepatitis C in blood donors in the Republic of Djibouti. Med Trop (Mars). 2005;65(1):39-42.
  28. 28 Gurol E, Saban C, Oral O, Cigdem A, Armagan A. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol. 2006;21(4):299-305. [DOI]
  29. 29 Available: https://doi.org/10.1007/s10654-006-0001-2. [DOI]
  30. 30 Mujeeb SA, Pearce MS. Temporal trends in hepatitis B and C infection in family blood donors from interior Sindh, Pakistan. BMC Infect Dis. 2008;8:43. [DOI]
  31. 31 Available: https://doi.org/10.1186/1471-2334-8-43. [DOI]
  32. 32 Asim M, Ali R, Khan LA, Husain SA, Singla R, Kar P. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion. Indian J Med Res. 2010;132:312-7.
  33. 33 Al-Rubaye A, Tariq Z, Alrubaiy L. Prevalence of hepatitis B seromarkers and hepatitis C antibodies in blood donors in Basra, Iraq. BMJ Open Gastroenterol. 2016;3(1). [DOI]
  34. 34 Available: https://doi.org/10.1136/bmjgast-2015-000067. [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.